Cell Surface Marker Market (By Component- Flow Cytometer, Hematology Analyzer and Reagents and Kits. By Cell Type- T Cell, B Cell and NK Cell. By Application- Research and Clinical and By Regions)– Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2018 – 2026

The cell surface marker market was valued at USD 491.4 Million in 2017 and is expected to become USD 966.06 Million market by 2026 growing at a Compound annual growth rate (CAGR) of 7.80% from 2018 to 2026. Increasing demand for stem cell research and rising prevalence of cancer is expected to augment the growth of the global market during the forecast period. In addition, increasing investment towards drugs discovery by private and public enterprises coupled with the continuous technological upgradation in the cell-based therapies and research such as commercialization of cell-based assays, cell counters and 3D cell culture technology is further anticipated to drive the global cell surface marker market during the forecast period.

Clinical segment is estimated to witness significant growth

The market has been segmented based on component which is further divided into flow cytometer, hematology analyzer and reagents and kits. In addition, cell surface marker market is further segmented based on cell type which is further sub segmented as T Cell, B Cell and NK Cell. Based on application, the market has been segmented into research and clinical. Clinical segment is expected to witness at the highest CAGR owing to the increasing demand for patient migration to access improved treatment during prevalence of chronic diseases such as HIV and cancer. In addition, increasing private investments for building advanced clinics and hospitals are further expected to create massive demand for clinical segment during the forecast period.

North America holds the largest market share by region

The global market has been geographically segmented into Asia-Pacific, Europe, North America, Latin America, the Middle East and Africa region. In addition to this, North America region holds the largest market share. The reason may be attributed to the massive investment towards R&Ds of latest therapies for chronic diseases and drug discovery. Increased health awareness regarding improved diagnostics and presence of well-established manufacturers of cell surface maker have further driven the demand for cell surface marker industry. However, rising medical tourism coupled with massive FDIs by the healthcare companies in the developing nations of Asia-Pacific region such as China, India, Singapore, Indonesia and others are further expected to stimulate the market revenue during the forecast period. Thereby, Asia-Pacific region is expected to witness significant growth rate.

Major Players in Cell Surface Marker Market

Some of the key players in the global cell surface marker market include Abbott Laboratories, BD Biosciences, Beckman Coulter, Bio-Rad Laboratories, Cell Signaling Technology, Danaher Corporation, Grifols SA, Merck KGaA, Roche Diagnostics and Siemens Healthcare.

The Cell Surface Marker Market has been segmented as follows:

Global Cell Surface Marker Market: By Component

·         Flow Cytometer

·         Hematology Analyzer

·         Reagents and Kits

Global Cell Surface Marker Market: By Cell Type

·         T Cells

·         B Cells

·         NK Cells

Global Cell Surface Marker Market: By Application

·         Research

o    Immunological

o    Stem Cell

·         Clinical

o    Oncology

o    Hematology

o    Others

Global Cell Surface Marker Market: By Geography

·         North America

o    U.S.

o    Canada

o    Mexico

·         Europe

o    U.K.

o    France

o    Germany

o    Italy

o    Rest of Europe

·         Asia Pacific

o    India

o    China

o    Japan

o    Rest of Asia Pacific

·         Middle East and Africa

o    South Africa

o    Rest of Middle East and Africa

·         Latin America

o    Brazil

o    Rest of Latin America